KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Net Cash Flow (2017 - 2025)

Historic Net Cash Flow for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to -$35.0 million.

  • Elanco Animal Health's Net Cash Flow fell 15303.03% to -$35.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0 million, marking a year-over-year decrease of 7407.41%. This contributed to the annual value of $207.0 million for FY2024, which is 98947.37% up from last year.
  • According to the latest figures from Q3 2025, Elanco Animal Health's Net Cash Flow is -$35.0 million, which was down 15303.03% from $25.0 million recorded in Q2 2025.
  • Elanco Animal Health's 5-year Net Cash Flow high stood at $193.0 million for Q4 2021, and its period low was -$291.0 million during Q1 2022.
  • Moreover, its 5-year median value for Net Cash Flow was $12.0 million (2024), whereas its average is $4.9 million.
  • As far as peak fluctuations go, Elanco Animal Health's Net Cash Flow tumbled by 95588.24% in 2022, and later skyrocketed by 122000.0% in 2024.
  • Elanco Animal Health's Net Cash Flow (Quarter) stood at $193.0 million in 2021, then plummeted by 176.17% to -$147.0 million in 2022, then surged by 88.44% to -$17.0 million in 2023, then soared by 423.53% to $55.0 million in 2024, then plummeted by 163.64% to -$35.0 million in 2025.
  • Its Net Cash Flow stands at -$35.0 million for Q3 2025, versus $25.0 million for Q2 2025 and -$10.0 million for Q1 2025.